Scanners IndustryThe global positron emission tomography (PET) scanners market is set to experience significant growth, with an estimated valuation of USD 1.3 billion in 2023 and a projected increase ...

Motion correction in imaging techniques like Positron Emission Tomography (PET) and Computed Tomography (CT) is crucial for obtaining high-quality images that accurately reflect the physiological ...

With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...

POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (Positron Emission ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and ...

Prolonged rapid eye movement (REM) latency may be a potential marker for Alzheimer disease and Alzheimer disease and related dementias (AD/ADRD).

Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic, APAC, to primarily support the initiation of a Phase IIa trial for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...